Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01662804
Brief Title: Humanized 3F8 Monoclonal Antibody (Hu3F8) When Combined With Interleukin-2 in Patients With High-Risk Neuroblastoma and GD2-positive Solid Tumors

First Submitted : August 7, 2012
First Submitted that Met QC Criteria : August 7, 2012
First Posted : August 10, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : March 5, 2021
Last Update Posted : March 8, 2021